TB-500 Fragment 17-23

Description

TB-500 Fragment 17-23 — Hexapeptide, BPC-157 Sub-Sequence

TB-500 Fragment 17-23 is a synthetic hexapeptide corresponding to a short sequence within the BPC-157 peptide. It is supplied for in vitro laboratory research only.

Research context

Preclinical literature has examined this fragment in angiogenesis assays and in studies of fibroblast proliferation and VEGF pathway signaling. Investigators have studied its effect on tendon- and ligament-derived cell migration using in vitro cell-migration (scratch) assay models. Model systems include endothelial and fibroblast cell cultures used to examine growth-factor signaling cascades.

Specification

• Available sizes: 10mg
• Form: lyophilised powder
• Purity: ≥99% (HPLC)
• Testing: independently lot-tested by Horizon Analytical · Certificate of Analysis per lot

For laboratory research use only. This material is supplied to qualified researchers and institutions for in vitro investigational use. It is not a drug, food, cosmetic or medical device. It is not intended for human or veterinary use, for diagnosis, treatment, cure or prevention of any disease, or for any use outside a controlled laboratory environment. No statement on this site has been evaluated by the Food and Drug Administration. Keep out of reach of children.

Related Research

Compound family: TB-500, IGF-1 LR3, BPC-157, PEG-MGF

Browse: Cellular & Tissue Research · All Research Peptides

Reconstitution & Lab Testing: All products independently tested by Horizon Analytical. See our Reconstitution & Lab Testing FAQ. Reconstitution typically requires BAC Water.